These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12845880)

  • 41. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris.
    Stammen F; De Scheerder I; Glazier JJ; Van Lierde J; Vrolix M; Willems JL; De Geest H; Piessens J
    Am J Cardiol; 1992 Jun; 69(19):1533-7. PubMed ID: 1598865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary angioplasty in patients with unstable angina: clinical, electrocardiographic and angiographic predictors of in-hospital outcome. R.OS.A.I. Study Group.
    Dellavalle A; De Servi S; Repetto S; Chierchia S; Repetto A; Vado A; Steffenino G
    Ital Heart J; 2000 Aug; 1(8):555-61. PubMed ID: 10994937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of Braunwald's clinical classification of unstable angina pectoris with angiographic extent of disease, lesion morphology and intra-luminal thrombus.
    Calton R; Satija T; Dhanoa J; Jaison TM; David T
    Indian Heart J; 1998; 50(3):300-6. PubMed ID: 9753852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of unstable angina pectoris/non-ST-segment elevation myocardial infarction in elderly patients.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2003 Oct; 58(10):M927-33. PubMed ID: 14570861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty.
    Gurbel PA; Navetta FI; Bates ER; Muller DW; Tenaglia AN; Miller MJ; Muhlstein B; Hermiller JB; Davidson CJ; Aguirre FV; Beauman GJ; Berdan LG; Leimberger JD; Bovill EG; Christenson RH; Ohman EM
    Cathet Cardiovasc Diagn; 1996 Apr; 37(4):382-91. PubMed ID: 8721695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
    van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
    Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era.
    Hoenig MR; Doust JA; Aroney CN; Scott IA
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004815. PubMed ID: 16856061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
    Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients at low risk for periprocedural myocardial infarction can be identified by assessment immediately following percutaneous coronary intervention.
    Mahmud E; Shaw KD; Penny WF
    J Invasive Cardiol; 2003 Jun; 15(6):343-7. PubMed ID: 12777674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
    Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
    Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
    Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
    Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.
    Hong YJ; Jeong MH; Lee SH; Park OY; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Park JC; Suh SP; Ahn BH; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):167-73. PubMed ID: 14619386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Coronary angioplasty in unstable angina at rest. Influence of the degree of clinical instability on the immediate and long-term results].
    Cavallini C; Olivari Z; Risica G; Cannarozzo PP; Marton F; Grisolia EF; Giommi L; Stritoni P
    G Ital Cardiol; 1996 Jun; 26(6):647-55. PubMed ID: 8803586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.